Resmed Q3 FY2026 Earnings: What Investors Need to Know Arrives April 30

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) announced today its schedule for the release of financial and operational figures for the third quarter of fiscal year 2026. The medical device company plans to make these results public on Thursday, April 30, 2026, once the New York Stock Exchange concludes its trading day. Following the official announcement, Resmed's leadership team will conduct a webcast. This session is designed to delve into the recently published results, and may also cover additional material and forward-looking business insights.

Based on Ranked Stocks' quantitative analysis, Resmed (RMD) currently holds an RS Score of 73.27, placing it in the 63.80th percentile both within its country and sector. The stock demonstrates strong performance in areas such as Profitability, scoring 92.62, and EPS Revisions, with an impressive 96.00. However, aspects like Valuation (72.21), Growth (71.53), and particularly Momentum (25.44) appear to be weaker areas. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.